iRhythm Holdings, Inc. Payments to Acquire Marketable Securities
iRhythm Holdings, Inc. (IRTC) reported Payments to Acquire Marketable Securities of $254.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- iRhythm Holdings, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $160.42M, a 18.70% increase year-over-year.
- iRhythm Holdings, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $94.03M, a 173.98% increase year-over-year.
- iRhythm Holdings, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $125.58M, a 8.43% increase year-over-year.
- iRhythm Holdings, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $171.07M.
- iRhythm Holdings, Inc. payments to acquire marketable securities for fiscal 2025 was $466.11M, a 294.21% increase from fiscal 2024.
- iRhythm Holdings, Inc. payments to acquire marketable securities for fiscal 2024 was $118.24M, a 28.03% decline from fiscal 2023.
- iRhythm Holdings, Inc. payments to acquire marketable securities for fiscal 2023 was $164.28M, a 12.88% decline from fiscal 2022.
- iRhythm Holdings, Inc. payments to acquire marketable securities for fiscal 2022 was $188.57M, a 54.33% increase from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $160.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $254.45M 10-Q · filed 2026-08-06 | $380.03M derived: sum of 3 quarters · filed 2026-08-06 | $551.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $94.03M 10-Q · filed 2026-04-30 | $219.60M derived: sum of 2 quarters · filed 2026-04-30 | $390.68M derived: sum of 3 quarters · filed 2026-04-30 | $525.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $125.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $296.65M derived: sum of 2 quarters · filed 2026-02-19 | $431.79M derived: sum of 3 quarters · filed 2026-08-06 | $466.11M 10-K · filed 2026-02-19 |
| 2025-09-30 | $171.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $306.22M derived: sum of 2 quarters · filed 2026-08-06 | $340.54M 10-Q · filed 2025-10-30 | $456.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $135.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $169.47M 10-Q · filed 2026-08-06 | $285.28M derived: sum of 3 quarters · filed 2026-08-06 | $285.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $34.32M 10-Q · filed 2026-04-30 | $150.13M derived: sum of 2 quarters · filed 2026-04-30 | $150.13M derived: sum of 3 quarters · filed 2026-04-30 | $150.13M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $115.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $115.81M derived: sum of 2 quarters · filed 2026-02-19 | $115.81M derived: sum of 3 quarters · filed 2026-02-19 | $118.24M 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $2.43M 10-Q · filed 2025-10-30 | $57.51M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.43M 10-Q · filed 2025-07-31 | $57.51M derived: sum of 3 quarters · filed 2026-02-19 | $93.86M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $2.43M 10-Q · filed 2025-05-01 | $57.51M derived: sum of 2 quarters · filed 2026-02-19 | $93.86M derived: sum of 3 quarters · filed 2026-02-19 | $132.95M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $55.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $91.43M derived: sum of 2 quarters · filed 2026-02-19 | $130.53M derived: sum of 3 quarters · filed 2026-02-19 | $164.28M 10-K · filed 2026-02-19 |
| 2023-09-30 | $36.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $75.44M derived: sum of 2 quarters · filed 2024-10-30 | $109.20M 10-Q · filed 2024-10-30 | $160.22M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $39.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $72.85M 10-Q · filed 2024-08-01 | $123.87M derived: sum of 3 quarters · filed 2025-02-20 | $169.90M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $33.76M 10-Q · filed 2024-05-02 | $84.78M derived: sum of 2 quarters · filed 2025-02-20 | $130.81M derived: sum of 3 quarters · filed 2025-02-20 | |
| 2022-12-31 | $51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $97.05M derived: sum of 2 quarters · filed 2025-02-20 | $188.57M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $46.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $137.55M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $91.52M 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $122.18M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |